We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,779 results
  1. Computer-Aided Drug Discovery and Design: Recent Advances and Future Prospects

    Computer-aided drug discovery and design involve the use of information technologies to identify and develop, on a rational ground, chemical...
    Protocol 2024
  2. AI-Driven Enhancements in Drug Screening and Optimization

    The greatest challenge in drug discovery remains the high rate of attrition across the different phases of the process, which cost the industry...
    Adam Serghini, Stephanie Portelli, David B. Ascher in Computational Drug Discovery and Design
    Protocol 2024
  3. Techniques for Develo** Reliable Machine Learning Classifiers Applied to Understanding and Predicting Protein:Protein Interaction Hot Spots

    With machine learning now transforming the sciences, successful prediction of biological structure or activity is mainly limited by the extent and...
    Jiaxing Chen, Leslie A. Kuhn, Sebastian Raschka in Computational Drug Discovery and Design
    Protocol 2024
  4. Cellular Blood Flow Modeling with HemoCell

    Many of the intriguing properties of blood originate from its cellular nature. Bulk effects, such as viscosity, depend on the local shear rates and...
    Gabor Zavodszky, Christian Spieker, ... Britt van Rooij in High Performance Computing for Drug Discovery and Biomedicine
    Protocol 2024
  5. Alchemical Free Energy Workflows for the Computation of Protein-Ligand Binding Affinities

    Alchemical free energy methods can be used for the efficient computation of relative binding free energies during preclinical drug discovery stages....
    Anna M. Herz, Tahsin Kellici, ... Julien Michel in High Performance Computing for Drug Discovery and Biomedicine
    Protocol 2024
  6. HPC Framework for Performing in Silico Trials Using a 3D Virtual Human Cardiac Population as Means to Assess Drug-Induced Arrhythmic Risk

    Following the 3 R’s principles of animal research—replacement, reduction, and refinement—a high-performance computational framework was produced to...
    Jazmin Aguado-Sierra, Renee Brigham, ... Constantine Butakoff in High Performance Computing for Drug Discovery and Biomedicine
    Protocol 2024
  7. High-Throughput Structure-Based Drug Design (HT-SBDD) Using Drug Docking, Fragment Molecular Orbital Calculations, and Molecular Dynamic Techniques

    Structure-based drug design (SBDD) is rapidly evolving to be a fundamental tool for faster and more cost-effective methods of lead drug discovery....
    Reuben L. Martin, Alexander Heifetz, ... Andrea Townsend-Nicholson in High Performance Computing for Drug Discovery and Biomedicine
    Protocol 2024
  8. A Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantification of Ethyl Glucuronide and Ethyl Sulfate in Urine

    Ethyl glucuronide and ethyl sulfate emerged as the biomarkers of choice for detection of ethanol use as the required sample is urine, enabling easy...
    Justin Dowis, **ang He, ... Deborah French in Clinical Applications of Mass Spectrometry in Drug Analysis
    Protocol 2024
  9. Quantitative LC-MS/MS Analysis of Opiates and Opioids in Human Urine

    We hereby present a direct, clinical LC-MS/MS assay for the simultaneous analysis of opiates and opioids in human urine. The assay is used as...
    Putuma P. Gqamana, Y. Victoria Zhang in Clinical Applications of Mass Spectrometry in Drug Analysis
    Protocol 2024
  10. Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Plasma Busulfan

    Busulfan is an alkylating agent and functions as a myeloablative and anti-leukemic chemotherapy drug. It is widely used with cyclophosphamide for...
    Uttam Garg, Ada Munar, C. Clinton Frazee in Clinical Applications of Mass Spectrometry in Drug Analysis
    Protocol 2024
  11. Triazole Antifungal Quantification for Therapeutic Drug Monitoring in Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Posaconazole, Voriconazole, Itraconazole, and Hydroxyitraconazole

    Antifungal therapy with triazole drugs including posaconazole, voriconazole, itraconazole, and its active metabolite hydroxyitraconazole is routinely...
    Mark Girton, Jose Tomsig, Lindsay Bazydlo in Clinical Applications of Mass Spectrometry in Drug Analysis
    Protocol 2024
  12. Liquid Chromatography-Tandem Mass Spectrometry-Based Therapeutic Monitoring of Plasma Atovaquone Concentrations in Pediatric Patients

    Atovaquone is an FDA-approved antiparasitic and antifungal therapeutic that is currently used as a prophylactic agent to prevent Pneumocystis carinii...
    Thomas D. Horvath, Sridevi Devaraj in Clinical Applications of Mass Spectrometry in Drug Analysis
    Protocol 2024
  13. Caenorhabditis elegans as an In Vivo Model Organism to Elucidate Teratogenic Effects

    Exogenous teratogens contribute to approximately 10% of the human abnormality with exposure occurrence during the prenatal and fetal period. However,...
    Zhenglu Wang in Teratogenicity Testing
    Protocol 2024
  14. Angiogenesis Assay for Live and Fixed Zebrafish Embryos/Larvae

    Angiogenesis is the process of new blood vessel formation from preexisting vasculature. It is an integral component in normal embryonic development...
    S. Vinoth, Satheeswaran Balasubramanian, ... Kirankumar Santhakumar in Teratogenicity Testing
    Protocol 2024
  15. A Stereological Approach to Quantify Immunohistochemical Staining in Zebrafish Larvae

    Immunohistochemistry (IHC) is a powerful research tool to localize specific antigens in whole-mount or tissue sections of embryos with labeled...
    Dércia Santos, Sandra M. Monteiro, Ana Luzio in Teratogenicity Testing
    Protocol 2024
  16. Detection of Pre-Existing Antibodies to Polyethylene Glycol and PEGylated Liposomes in Human Serum

    Polyethylene glycol, or PEG, is common in consumer products, over-the-counter medications, food, and pharmaceutical products. Concerns about PEG...
    Barry W. Neun, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  17. Accelerating the Discovery and Design of Antimicrobial Peptides with Artificial Intelligence

    Peptides modulate many processes of human physiology targeting ion channels, protein receptors, or enzymes. They represent valuable starting points...
    Mariana d. C. Aguilera-Puga, Natalia L. Cancelarich, ... Fabien Plisson in Computational Drug Discovery and Design
    Protocol 2024
  18. Natural Language Processing for Drug Discovery Knowledge Graphs: Promises and Pitfalls

    Building and analyzing knowledge graphs (KGs) to aid drug discovery is a topical area of research. A salient feature of KGs is their ability to...
    J. Charles G. Jeynes, Tim James, Matthew Corney in High Performance Computing for Drug Discovery and Biomedicine
    Protocol 2024
  19. A Blood Flow Modeling Framework for Stroke Treatments

    Circulatory models can significantly help develop new ways to alleviate the burden of stroke on society. However, it is not always easy to know what...
    Remy Petkantchin, Franck Raynaud, ... Bastien Chopard in High Performance Computing for Drug Discovery and Biomedicine
    Protocol 2024
  20. High-Throughput Quantitative LC-MS/MS Analysis of Benzodiazepines in Human Urine

    We hereby present a fast, high-throughput, and clinical LC-MS/MS assay for the simultaneous analysis of benzodiazepines in human urine. The assay is...
    Putuma P. Gqamana, Y. Victoria Zhang in Clinical Applications of Mass Spectrometry in Drug Analysis
    Protocol 2024
Did you find what you were looking for? Share feedback.